Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China NT Pharma Group Co., Ltd. ( (HK:1011) ) just unveiled an announcement.
China NT Pharma Group Company Limited has convened its annual general meeting for 4 June 2026 in Hong Kong to review and adopt the audited consolidated financial statements and directors’ and auditors’ reports for the financial year ended 31 December 2025. Shareholders will also vote on the re-election of three retiring directors, the authorization of directors’ remuneration, and the re-appointment of Moore CPA Limited as the company’s auditors.
The meeting will further seek shareholder approval to grant the board a general mandate to issue up to 20% of the company’s existing share capital, including related options, warrants, and convertible securities, subject to Hong Kong listing rules. This proposed issuance mandate, which is additional to existing authorisations, would enhance the company’s financial and strategic flexibility by enabling potential capital raising, corporate transactions, or incentive schemes without requiring separate approvals for each action.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Company Limited is a Hong Kong–listed company incorporated in the Cayman Islands and traded under stock code 1011. It operates within the healthcare and pharmaceutical sector, with its governance and capital management subject to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
Average Trading Volume: 251,362
Technical Sentiment Signal: Sell
Current Market Cap: HK$635.8M
For detailed information about 1011 stock, go to TipRanks’ Stock Analysis page.